Aidapak Services, LLC recalls ORPHENADRINE CITRATE ER Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 43386048024
Recalled January 22, 2014 · FDA recall D-566-2014 · Aidapak Services
Hazard
Labeling: Label Mixup; ORPHENADRINE CITRATE ER Tablet, 100 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W002965, EXP: 6/10/2014. · FDA Class II
Units
100 Tablets
Sold at
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Description
Labeling: Label Mixup; ORPHENADRINE CITRATE ER Tablet, 100 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W002965, EXP: 6/10/2014.
Product
ORPHENADRINE CITRATE ER Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 43386048024
Manufacturer(s)
Aidapak Services, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →